Validity of serum amyloid A and HMGB1 as biomarkers for early diagnosis of gastric cancer

BACKGROUND AND AIM: Gastric carcinomais a frequent neoplasm with poor outcome, and its early detection would improve prognosis. This study was designed to evaluate the possible use of new biomarkers, namely SAA and HMGB1, for early diagnosis of gastric cancer. METHODS: A total of 100 patients presen...

Descripción completa

Detalles Bibliográficos
Autores principales: Ghweil, Ali A, Osman, Heba A, Hassan, Mohammed H, Sabry, Abeer MM, Mahdy, Reem E, Ahmed, Ahmed RH, Okasha, Ahmed, Khodeary, Ashraf, Ameen, Hesham H
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2020
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6958557/
https://www.ncbi.nlm.nih.gov/pubmed/32021428
http://dx.doi.org/10.2147/CMAR.S207934

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6958557/
https://www.ncbi.nlm.nih.gov/pubmed/32021428
http://dx.doi.org/10.2147/CMAR.S207934

Ejemplares similares